News & Articles

Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection

Prof. Silke Christiansen describes how she explores the mechanical properties of bone to help better treat osteoporosis and highlights the technological advances enabling new insights

Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is 70.4% effective when combining data from two dosing regimens

Two different dosing regimens demonstrated efficacy with one showing a better profile

Sangmi Han discusses how cell counters have become an integral part of Macrogen’s single-cell RNA sequencing workflow

Join us on Wednesday, December 2, to learn how the BioAccord LC-MS System delivers robust UPLC separations performance and accurate mass data for a diverse range of modified oligonucleotides

LC 300 platform and SimplicityChrom software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance

The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic

Watch this on-demand webinar to learn about the pathogenicity and transmission of Salmonella

As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working

In this webinar Aaron Hineman, PerkinElmer, will review a total ICP-MS solution for your pharmaceutical impurity testing needs

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

Join scientists from across the globe to explore the latest developments in biopharma, from new research techniques to cutting-edge technologies and resources to advance your work

Watch this on-demand webinar to find out how to use the dragonfly discovery to set up robust high-throughput assays quickly

QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes

Internationally renowned Hans Clevers Lab reports using AMSBIO’s CELLBANKER reagent to freeze down their organoids ahead of the COVID-19 spring lockdown

Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide

Exclusive interviews, free downloads, the latest methods and much more to help support your immuno-oncology research

The kit promises to be a low cost, high-sensitivity diagnostic test for COVID-19 detection